In this study, the activity concentrations of natural primordial radionuclides in fly ash (FA) samples collected from the landfill area of Afşin-Elbistan A lignite-fired thermal power plant (AE-A LFTPP) located in Kahramanmaraş province of Türkiye were measured using a gamma-ray spectrometer. Also, the radiological risk was assessed using the Residual Radioactivity Onsite 7.2 code. The average activity concentrations of 226Ra, 232Th and 40K in FA samples varied from 291 ± 10 to 853 ± 25 Bq/kg, 23 ± 1 to 125 ± 4 Bq/kg and 112 ± 10 to 315 ± 18 Bq/kg, respectively. The predicted maximum total annual effective dose rate due to the natural radionuclides and their progenies is 4.7, 4.4, and 4.0 mSv/y at t = 1000 y for 0.5-m, 1.25-m, and 2.0-m cover scenarios, respectively. While the predicted maximum total cancer risk is 4.56 × 10−3 (3.95 × 10−3 for 226Ra, 5.18 × 10−4 for 232Th and 6.14 × 10−15 for 40K), 4.00 × 10−3(3.80 × 10−3 for 226Ra, 1.90 × 10−4 for 232Th and 7.69 × 10−15 for 40K) and 3.71 × 10−3 (3.71 × 10−3 for 226Ra, 1.820 × 10−8 for 232Th and 7.66 × 10−15 for 40K) at t = 1000 y for 0.5-m, 1.25-m and 2.0-m cover scenario, respectively. Results also revealed that the total doses and cancer risks are less in thicker cover scenarios throughout the 1000 y time span and that 226Ra is the major contributor to the risk in all the scenarios owing to its higher activity concentration than 232Th and 40K.
No takes yet. Share an insight, caveat, or question.
Jamasalı et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: